amiodarone has been researched along with Overweight in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Overweight: A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Analysis of the pharmacokinetics of AMD was accomplished using a 1-compartment open pharmacokinetic model." | 1.37 | Population pharmacokinetic investigation for optimization of amiodarone therapy in Japanese patients. ( Araki, R; Fukuchi, H; Nakashima, M; Nakashima, MN; Sasaki, H; Yano, K; Yukawa, E, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, R | 1 |
| Yukawa, E | 1 |
| Nakashima, MN | 1 |
| Fukuchi, H | 1 |
| Sasaki, H | 1 |
| Yano, K | 1 |
| Nakashima, M | 1 |
1 other study available for amiodarone and Overweight
| Article | Year |
|---|---|
Population pharmacokinetic investigation for optimization of amiodarone therapy in Japanese patients.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Body Mass | 2011 |